NHS Framework Agreement for the supply of Ranibizumab for the NHS in England

Description

The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England.<br/>Anti Veg-F medicines are currently used in the treatment of: <br/>a. neovascular (wet) age-related macular degeneration (AMD);<br/>b. visual impairment due to diabetic macular oedema (DME/DMO);<br/>c. visual impairment due to myopic choroidal neovascularisation (myopic CNV); and<br/>d. visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO). Lot 1: The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England.<br/>Anti Veg-F medicines are currently used in the treatment of: <br/>a. neovascular (wet) age-related macular degeneration (AMD);<br/>b. visual impairment due to diabetic macular oedema (DME/DMO);<br/>c. visual impairment due to myopic choroidal neovascularisation (myopic CNV); and<br/>d. visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).